Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ImmunoGen, Inc.
The Netherlands Cancer Institute
Celldex Therapeutics
Duke University
Northwestern University
Xencor, Inc.
Tesaro, Inc.
Dana-Farber Cancer Institute
University of Washington
Roswell Park Cancer Institute